Net profit of Sandu Pharmaceuticals rose 4.00% to Rs 0.52 crore in the quarter ended September 2025 as against Rs 0.50 crore during the previous quarter ended September 2024. Sales declined 0.45% to Rs 17.62 crore in the quarter ended September 2025 as against Rs 17.70 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 17.62 | 17.70 | 0 |
| OPM % | 4.88 | 5.14 | - |
| PBDT | 0.88 | 0.91 | -3 |
| PBT | 0.71 | 0.74 | -4 |
| NP | 0.52 | 0.50 | 4 |